跳至主要内容
临床试验/NCT01070095
NCT01070095已完成不适用

The Electronic Asthma Action Plan System for Implementation in Primary Care

Unity Health Toronto3 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2012年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
19
试验地点
3
主要终点
Number of Participants to Whom an AAP (Asthma Action Plan) Was Delivered by the Clinician

研究概览

简要总结

Asthma is a common and potentially fatal chronic disease. An asthma action plan (AAP) is a written plan produced by a physician for a patient with asthma, to provide education and guidelines for self-management of worsening asthma symptoms. Studies have shown that AAPs effectively improve asthma control, but physicians fail to provide AAPs due to lack of time and adequate skills. Physicians also often fail to determine if their patients have good asthma control, and to adjust medications in response to patients' control level. The investigators propose to develop and test a computerized tool that will help physicians to determine if their patients' asthma is well controlled, advise them on medication changes required according to the current level of control, and automatically generate an electronic version of the AAP, all based on patient responses to a questionnaire. The investigators hope that this system will eliminate the barriers that physicians face in determining asthma control, adjusting medications, and delivering an AAP, and will increase the frequency with which physicians are able to achieve these goals in patients with asthma. The objectives of the study are to determine the impact of this system on asthma action plan delivery by primary care physicians, the frequency of checking control level, and the frequency and appropriateness of asthma medication changes (in accordance with control). We will also attempt to determine the impact of the system on hospitalisations, emergency room (ER) visits, unscheduled visits to the doctor, total visits to the doctor, days off work or school, nocturnal asthma symptoms, daytime asthma symptoms, daytime rescue puffer use, and quality of life, and to measure physicians' perceptions of and satisfaction with the system.

详细描述

This is a 2-year prospective interrupted time series (ITS) study of usual asthma care (baseline period) (year 1) compared to care with the eAAPS in place (intervention period) (year 2). The setting is two academic family health teams (primary health care teams including family physicians, nurses, and allied health members) in Hamilton, Ontario and one community-based family health team in Brampton, Ontario.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Eligible physicians will include all primary care physicians at the 4 sites.
  • •Eligible patients will include:
  • •patients with asthma, as determined by a validated electronic chart record search algorithm for asthma and on an asthma medication [but not a Chronic Obstructive Pulmonary Disease (COPD) medication] within 1 year;
  • •patients >/= 16 years of age who understand English

排除标准

  • •Pregnant patients will be excluded given that conventional AAP recommendations may not be appropriate in this population.
  • •Any patient deemed to have cognitive limitations or a life expectancy of < 1 year

研究组 & 干预措施

Electronic Asthma Action Plan System

Experimental

Electronic Asthma Action Plan System (eAAPS)

干预措施: Electronic Asthma Action Plan System (Other)

结局指标

主要结局

Number of Participants to Whom an AAP (Asthma Action Plan) Was Delivered by the Clinician

时间窗: 24 months

Number of eligible patients to whom an AAP was delivered by the physician during the intervention period (52 weeks) compared to the baseline period (52 weeks) Predictor model to include: clinic, appointment provider practitioner type, prior objective diagnosis of asthma, documented physician diagnosis of asthma, presenting complaint type, billing physician (most responsible physician/other), previous emergency department (ED) visits/hospitalizations for asthma, and current asthma control

次要结局

  • The Impact of the eAAPS on Patient-relevant Outcomes Including Hospitalisations, Emergency Room Visits, Unscheduled & Total Visits to the Doctor, Days Off Work/School, Nocturnal/Daytime Asthma Symptoms, Daytime Rescue Bronchodilator Use & Quality of Life.(Every 2 weeks for 6 months)
  • Medication Escalations(24 months)
  • Number of Practitioners Completing Feedback Questionnaires(13 months)
  • Ratio of Rescue to Controller Medication Prescriptions(24 months)
  • Adherence Discussions(During the 12 month intervention period)
  • System Uptake(During the 12 month intervention period)
  • Asthma Control Assessment(24 months)
  • Appropriate Medication Changes(24 months)
  • On Treatment Analysis(During the 12 month intervention period)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验